Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
Diagnosis & Disease Information
Uterine Cancer Mortality on the Rise, but Research Remains Underfunded
Though mortality rates for uterine cancer are on the rise, research for this cancer is underfunded, a study suggests.
Minimally Invasive Surgery Linked to Longer Survival in Advanced Ovarian Cancer
Patients with advanced ovarian cancer may live longer if they undergo minimally invasive surgery rather than laparotomy, a study suggests.
Ultra-Processed Food Linked to Increased Risk of Cancer and Death
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
Risks of Sexual Dysfunction Higher for Survivors of Gynecologic Cancers
Researchers sought to determine whether survivors of gynecologic cancers had a higher risk of sexual dysfunction, compared with cancer-free women, and the risk factors for sexual dysfunction.
Zejula Use for Second-Line Maintenance Treatment Restricted
The decision to restrict the indication follows an FDA review of the double-blind, placebo-controlled phase 3 ENGOT-OV16/NOVA trial.
Elahere Granted Accelerated Approval for Platinum-Resistant Ovarian Cancer
The approval was based on data from the SORAYA trial.
Mirvetuximab Soravtansine Granted Priority Review for Ovarian Cancer
Mirvetuximab soravtansine is an antibody-drug conjugate comprised of a FRα-binding antibody, a cleavable linker, and a potent tubulin-targeting agent.
Cancer Researchers Aren’t Reporting Quality of Life Outcomes Accurately
Quality of life outcomes were reported favorably for trials that showed no improvement in quality of life.
Nemvaleukin Alfa Plus Pembrolizumab Fast Tracked for Platinum-Resistant Ovarian Cancer
The antitumor activity and safety of nemvaleukin alfa plus pembrolizumab is being investigated in the open-label, randomized, phase 3 ARTISTRY-7 trial.
- Loading...
Loading...
Next post in News
Loading... 
Loading...